Dasatib Tablets – Product Description, Uses, Benefits and Side Effects

Product Overview

Dasatib Tablets 50 mg, 70 mg and 100 mg contain dasatinib, a prescription medicine belonging to the tyrosine kinase inhibitor (TKI) class. Dasatinib is used in the treatment of specific types of leukemia, including chronic myeloid leukemia (CML) and certain cases of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), depending on the patient's diagnosis and applicable prescribing guidelines.

Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical product information to support healthcare professionals, pharmaceutical distributors and international medicine buyers seeking information about oncology medicines. Product availability, packaging and export requirements should be confirmed directly with the company.

Available Strengths of Dasatib Tablets

Dasatib Tablets are highlighted in three strengths:

Dasatib 50 mg Tablets: A strength that may be prescribed as part of an individualized leukemia treatment plan.

Dasatib 70 mg Tablets: Used when the prescribed treatment regimen calls for this specific strength.

Dasatib 100 mg Tablets: A strength commonly associated with adult treatment regimens for chronic-phase CML, when prescribed by a qualified specialist.

The appropriate strength depends on the leukemia subtype, treatment history, patient response, blood test results and tolerability. These strengths are not interchangeable without medical guidance.

Uses and Potential Benefits of Dasatib Tablets

Dasatinib works by inhibiting specific proteins called tyrosine kinases that contribute to the growth and survival of certain leukemia cells.

Its medically established uses may include:

Chronic Myeloid Leukemia (CML): Used for eligible patients with Philadelphia chromosome-positive CML, according to the applicable prescribing information.

Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): May be prescribed for eligible patients under approved treatment protocols.

Targeted cancer treatment: Acts on specific molecular pathways involved in leukemia rather than functioning as a general pain-relief or infection-treatment medicine.

Treatment outcomes vary between patients. Dasatinib is not a cure guaranteed for every patient, and therapy requires ongoing supervision by a qualified oncology specialist.

Side Effects of Dasatib (Dasatinib) Tablets

Like other prescription oncology medicines, dasatinib can cause side effects. Commonly reported effects include:

Headache and fatigue

Nausea and diarrhoea

Skin rash

Muscle, joint or bone pain

Fluid retention and swelling

Shortness of breath

More serious risks include low blood cell counts, bleeding, fluid around the lungs, cardiovascular complications and pulmonary arterial hypertension.

Important safety advice: Seek urgent medical attention for severe breathing difficulties, unusual bleeding, black stools, chest pain or signs of a serious infection. Regular blood tests and clinical monitoring are essential during treatment.

Frequently Asked Questions (FAQs)

1. What is Dasatib used for?

Dasatib contains dasatinib, a targeted prescription medicine used for specific types of leukemia, including eligible cases of CML and Ph+ ALL.

2. What strengths of Dasatib Tablets are available?

This product page highlights Dasatib 50 mg, 70 mg and 100 mg Tablets. Confirm the exact product, registration status and availability with the supplier.

3. Is Dasatib 100 mg suitable for every patient?

No. The correct dose depends on the diagnosis, treatment phase, individual health factors and specialist assessment. Never adjust the dose yourself.

4. What are the common side effects of Dasatib?

Common effects include headache, fatigue, nausea, diarrhoea, rash and fluid retention. Serious side effects require prompt medical evaluation.

5. Can Dasatib Tablets be purchased without a prescription?

Dasatinib is a prescription oncology medicine and should only be used under qualified medical supervision. Buyers must comply with applicable prescription, pharmaceutical import and local regulatory requirements.

Contact Cordium Pharmaceuticals Pvt Ltd

For product enquiries concerning Dasatib Tablets 50 mg, 70 mg and 100 mg, contact Cordium Pharmaceuticals Pvt Ltd to confirm product specifications, documentation, current availability and applicable export requirements.

Medical disclaimer: This content is for general educational and product-information purposes only. It does not replace professional medical advice, an approved product label or an oncology specialist's recommendations.